Skip to main content
. 2019 Dec 15;11(12):2024. doi: 10.3390/cancers11122024

Table 2.

Anti-MM CAR T cell targeting antigens other than BCMA and CD19.

Target Construct Clinical trial Response References
Kappa light chain CD28 Done 5/8: SD [34]
SLAMF7 CD28 Not reported yet - [35]
BCMA/TACI
(APRIL)
CD28 Not reported yet - [36]
GPRC5D 4-1BB Not reported yet - [37]
Activated integrin β7 CD28 Not reported yet - [38]